Exagen Inc. to Participate in Fourth Quarter Investor Conferences
13 Novembre 2024 - 10:05PM
Exagen Inc. (Nasdaq: XGN), a leading provider of
autoimmune testing solutions, today announced that management will
participate in the following upcoming investor conferences:
Canaccord Genuity MedTech, Diagnostics and Digital
Health & Services Forum
Company presentation by John Aballi, President and CEO on
Thursday, November 21, 2024, at 3:00 p.m. EST at the Westin NY
Grand Central Hotel. Management will also participate in one-on-one
investor meetings.
Evercore HEALTHCONx Conference
Company presentation by John Aballi, President and CEO on
Wednesday, December 4, 2024, at 12:30 p.m. EST at The Lowes Coral
Gables Hotel in Coral Gables, FL. Management will also participate
in one-on-one investor meetings.
TD Cowen Diagnosing Tomorrow Conference – Tools and
Technologies for the Next Decade
John Aballi, President and CEO, with participate in a panel
discussion titled: Beyond Cancer on Thursday, December 12, 2024, at
2:40 p.m. EST at One Vanderbilt, 20th Floor, New York, NY.
About Exagen Inc.
Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune
diagnostics, committed to transforming care for patients with
chronic and debilitating autoimmune conditions. Based in San Diego
County, Calif., Exagen’s mission is to provide clarity in
autoimmune disease decision making and improve clinical outcomes
through its innovative testing portfolio. The company’s flagship
product, AVISE® CTD, enables clinicians to more effectively
diagnose complex autoimmune conditions such as lupus, rheumatoid
arthritis, and Sjögren’s syndrome earlier and with greater
accuracy. Exagen’s laboratory specializes in the testing of
rheumatic diseases, delivering precise and timely results,
supported by a full suite of AVISE-branded tests for disease
diagnosis, prognosis, and monitoring. With a focus on research,
innovation, education, and patient-centered care, Exagen is
dedicated to addressing the ongoing challenges of autoimmune
disease management. For more information, visit Exagen.com or
follow @ExagenInc on X.
Exagen Inc.Ryan
DouglasIR@exagen.com760.560.1525
Grafico Azioni Exagen (NASDAQ:XGN)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Exagen (NASDAQ:XGN)
Storico
Da Dic 2023 a Dic 2024